Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants

International Journal of Cancer

Volumn 91, Issue 1, 2001, Pages 109-119

  Garcia Lora, Angel ^a   Algarra, Ignacio ^b   Gaforio, Jose J ^b   Ruiz Cabello, Francisco ^a   Garrido, Federico ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b UNIVERSITY OF JAÉN   (Spain)

Author keywords

T lymphocytes; Tumor variants

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; FIBROSARCOMA; GENE DELETION; IMMUNE RESPONSE; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR GROWTH;

ANIMALS; CELL SEPARATION; CHROMOSOME MAPPING; DNA, COMPLEMENTARY; EXONS; FIBROSARCOMA; FLOW CYTOMETRY; GENES, MHC CLASS I; INTERFERON TYPE II; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSATELLITE REPEATS; NEOPLASMS, EXPERIMENTAL; PHENOTYPE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SPLEEN; T-LYMPHOCYTES;

EID: 0035203631     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20010101)91:1<109::AID-IJC1017>3.0.CO;2-E     Document Type: Article

References (41)

1. MHC antigens and malignancy
2. Identification of human cancers deficient in antigen processing
3. Natural history of HLA expression during tumour development
4. HLA class I antigen down-regulation in human cancers: T cell immunotherapy revives an old story
5. HLA class I antigens in human tumors
6. Host MHC class I gene control of NK cell specificity in the mouse
7. Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells
8. A new beta 2 microglobulin mutation found in a melanoma tumor cell line
9. Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line
10. Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors
11. DNA binding of regulatory factors interacting with MHC-class I gene enhancer correlates with MHC class I transcriptional level in class I defective cell lines
12. MHC loss in colorectal tumors: Evidence for immunoselection?
13. Differences in the antigens recognized by cytolytic T cells on 2 successive metastases of a melanoma patient are consistent with immune selection
14. Characterization of an antigen that is recognized on a melanoma exhibiting partial HLA loss by CTL expressing an NK inhibitory receptor
15. The great escape: Is evasion required for tumour progression?
16. Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog
17. Influence of class I H-2 gene expression on local tumor growth
18. A weakly tumorigenic phenotype with high MHC class I expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma
19. NK sensitivity and lung clearance of MHC class I deficient cells within a heterogeneous fibrosarcoma
20. Heterogeneity of MHC-class I antigens in clones of methylcholantrene induced tumors. Implications for local growth and metastasis
21. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
22. Absence of 4 H-2d antigenic specificities in an H-2d sarcoma
23. Escape of human solid tumors from T-cell recognition: Molecular mechanisms and functional significance
24. The HLA crossroad m tumor immunology
25. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
26. Antitumor immunity at work in a melanoma patient
27. HLA and cancer: From research to clinical impact
28. Receptors for HLA class I molecules in human natural killer cells
29. NK cell receptor calibration: Effects of MHC class I induction on killing by Ly49Ahigh and Ly49Alow NK cells
30. Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses
31. Strain- and age-dependent natural and activated in vitro cytotoxicity in athymic nude mice
32. Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice
33. MCA sarcomas induced in scid mice are more immunogenic than MCA sarcomas induced in congenic, immunocompetent mice
34. Molecular studies of murine mutant BALB/c-H-2dm2 define a deletion of several class I genes including the entire H-2 L(d) gene
35. Molecular basis of the dm1 mutation in the major histocompatibility complex of the mouse: D/L hybrid gene
36. Locus-specific de novo methylation down-regulates MHC class I in S49 lymphomas
37. Mutation inside but not outside the peptide binding cleft of the H-2 L(d) molecule affect CTL recognition and binding of the nucleoprotein peptide from the lymphocytic choriomeningitis virus
38. The suceptibility to cytotoxic T lymphocyte mediated lysis of chemically induced sarcomas from immunodeficient and normal mice
39. Selective upregulation of MHC class I expression in metastatic colonies derived from tumor clones of a murine fibrosarcoma
40. Alphal/alpha2 domains of H-2D(d), but not H-2L(d), induce 'missing self' reactivity in vivo-no effect of H-2L(d) on protection against NK cells expressing the inhibitory receptor Ly49G2
41. High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas